Last reviewed · How we verify
NCT05452850
Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
trial testing Left and Right Ventricular Global Strain Imaging in Amyloid Cardiomyopathy in 30 participants. Status unknown.
26 September 2023
Quick facts
| Lead sponsor | Istanbul University - Cerrahpasa |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 11 August 2022 |
| Primary completion | 26 September 2023 |
| Estimated completion | 30 October 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Left and Right Ventricular Global Strain Imaging
Conditions studied
- Amyloid Cardiomyopathy — all drugs for Amyloid Cardiomyopathy →
- Congestive Heart Failure — all drugs for Congestive Heart Failure →
- Chemotherapy Effect — all drugs for Chemotherapy Effect →
Sponsor
Istanbul University - Cerrahpasa
Who can join
Adults 18 to 90, any sex, with Amyloid Cardiomyopathy or Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study to assess the longitudinal changes in left and right ventricular global strain after chemotherapeutic strategies in cardiac light chain amyloidosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05452850
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amyloid Cardiomyopathy
Currently open trials in the same condition.
- NCT07382128 — Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes · recruiting
- NCT06634108 — Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy · Phase 1, PHASE2 · recruiting
- NCT05797857 — Exercise Training in Transthyretin Cardiac Amyloidosis · NA · recruiting
- NCT05103943 — Amyloidosis TTR Flow Reserve Evaluation · NA · active not recruiting
- NCT04776824 — Swiss Cardiac Amyloidosis REgistry (Swiss-CARE) · recruiting
Other Istanbul University - Cerrahpasa trials
Trials by the same sponsor.
- NCT07588685 — Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Co · not yet recruiting
- NCT07370025 — The Effect of Lullaby During Bath Time on Mother-Infant Bonding, Postpartum Depression, and Parental Self-Efficacy in In · NA · not yet recruiting
- NCT07378449 — The Effect of Hand Exercise Hoops on Labour Pain · NA · not yet recruiting
- NCT07293000 — Evaluating Two Nursing Interventions to Prevent Urinary Retention After Spinal Anesthesia · NA · not yet recruiting
- NCT07562880 — Validity and Reliability of the Exercise-Related Health Beliefs Attitude Scale in Geriatric Individuals · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05452850 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul University - Cerrahpasa
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05452850.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing